Epidemiology, treatment and health care resource use of patients with severe asthma in Germany – a retrospective claims data analysis-Reference-Cited by-同舟云学术

Epidemiology, treatment and health care resource use of patients with severe asthma in Germany – a retrospective claims data analysis

Published:2022-12-01 Issue: Volume: Page:1-10
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Hardtstock Fraence¹^ORCID,Krieger Julia¹^ORCID,Wilke Thomas¹^ORCID,Lukas Marco²,Ultsch Bernhard²^ORCID,Welte Robert²,Quinzler Renate³,Maywald Ulf⁴,Timmermann Hartmut⁵

Affiliation:

1. IPAM, Real-World-Evidence, Wismar, Germany

2. GlaxoSmithKline GmbH & Co. KG, München, Germany

3. AOK Baden-Württemberg, Stuttgart, Germany

4. AOK PLUS, Dresden, Germany

5. Schwerpunktpraxis Colonnaden, Hamburg, Germany

Funder

GlaxoSmithKline GmbH & Co. KG

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2022.2144350

Reference51 articles.

1. World Health Organization. Chronic respiratory diseases: asthma [Internet]. Geneva: World Health Organization; 2020. https://www.who.int/news-room/questions-and-answers/item/chronic-respiratory-diseases-asthma [updated 3 May 2021; last accessed 10 October 2022].

2. Untangling asthma phenotypes and endotypes

3. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease

4. Asthma: prevalence and cost of illness

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exacerbations, treatment patterns, utilization, and costs before and after initiating of benralizumab for the treatment of severe eosinophilic asthma;Journal of Asthma;2023-12-06